Clinical Trial Update: Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating efficacy and safety of sirolimus for vascular malformations refractory to standard care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Malformations

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Vascular Malformations | Phase 3 | Status: RECRUITING